First Isolation of bla IMI-2 in an Enterobacter cloacae Clinical Isolate from China
- 1 April 2006
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (4), 1610-1
- https://doi.org/10.1128/aac.50.4.1610-1611.2006
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Carbapenemase-producingEnterobacteriaceae, U.S. RiversEmerging Infectious Diseases, 2005
- Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical CenterAntimicrobial Agents and Chemotherapy, 2004
- Acquired Carbapenem-Hydrolyzing Beta-Lactamases and their Genetic SupportCurrent Pharmaceutical Biotechnology, 2002
- Emerging carbapenemases in Gram-negative aerobesClinical Microbiology & Infection, 2002
- Identification of a Plasmid Encoding SHV-12, TEM-1, and a Variant of IMP-2 Metallo-β-Lactamase, IMP-8, from a Clinical Isolate of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Molecular and Biochemical Characterization of VEB-1, a Novel Class A Extended-Spectrum β-Lactamase Encoded by an Escherichia coli Integron GeneAntimicrobial Agents and Chemotherapy, 1999
- Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 1996
- A functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrobial Agents and Chemotherapy, 1995
- Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein.Proceedings of the National Academy of Sciences, 1994
- Genetic and DNA sequence analysis of the kanamycin resistance transposon Tn903.Proceedings of the National Academy of Sciences of the United States of America, 1980